<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:department>UNLISTED</gtr:department><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/8087A3C3-09A8-4495-8205-03AF95BFFB0E"><gtr:id>8087A3C3-09A8-4495-8205-03AF95BFFB0E</gtr:id><gtr:firstName>Jean</gtr:firstName><gtr:surname>Manson</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BBS%2FE%2FA%2F00001655"><gtr:id>0E058342-438A-48A4-8FE3-3293179C4F32</gtr:id><gtr:title>Investigating the role of glycosylation in the TSE's</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>BBS/E/A/00001655</gtr:grantReference><gtr:abstractText>The project objectives are to determine whether host PrP glycosylation influences the spread of infectivity from the periphery to the CNS and whether this is TSE strain dependent, to determine whether PrP glycosylation is important in the maintenance of TSE strain characteristics, to establish whether glycosylation processes are affected by TSE infection and to investigate the formation of plaques in PrP glycosylation-restricted mice.</gtr:abstractText><gtr:fund><gtr:end>2010-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2007-04-01</gtr:start><gtr:type>EXPENDITURE_PROJECTED</gtr:type><gtr:valuePounds>112832</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Prion 2016 chair and invited speaker</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>572F9E5D-8277-47FD-A433-66CA383CB9EC</gtr:id><gtr:impact>invited talk to international meeting</gtr:impact><gtr:outcomeId>58bd4b2822fce3.86560366</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other audiences</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>We have established that the glycosylation status of the prion protein has a major influence on host susceptibility to prion disease</gtr:description><gtr:exploitationPathways>We have produced unique lines of transgenic mice with different glycoforms of PrP. Theses mice have been made available to the scientific community worldwide</gtr:exploitationPathways><gtr:id>9DBE23EA-2AAD-4A81-88EC-64C5196BDBDF</gtr:id><gtr:outcomeId>56be0828bb91a7.56412056</gtr:outcomeId><gtr:sectors><gtr:sector>Other</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member of the ACDP</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>7B6C05F9-4CC8-41D9-BE04-90EE8982F04A</gtr:id><gtr:impact>The Advisory Committee on Dangerous pathogens advises the UK government on all issues related to dangerous pathogens from situations, in the field, in health care and laboratory practice. I serve on the committee as the expert on the Transmissible Spongiform Encephalopathies</gtr:impact><gtr:outcomeId>bvz7Yv6fNjU</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>WHO TSE Working Group</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>173E6B0C-A9B7-4FF9-B442-3EE54B571068</gtr:id><gtr:impact>developed policy on prion diseases</gtr:impact><gtr:outcomeId>qwPK2twTjcL</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member of the British Neuroscience Advisory Board</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>2C6C63E0-CF85-42F4-97B6-6AE4CC8CD9B7</gtr:id><gtr:outcomeId>pz9cTFBTzRy</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member of the European Food Safety Authority</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>2CE8C3B2-1D11-4BE6-B191-7A01B0430537</gtr:id><gtr:impact>involved in development of policy on prion diseases</gtr:impact><gtr:outcomeId>tLEj8xgWTLE</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member of the CJD Sample Oversight Committee Group</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>384F2526-3E88-4EB9-8042-223154B79D7A</gtr:id><gtr:impact>The committee aims to facilitate the development of diagnostics for vCJD through working with developers and providing access to rare samples</gtr:impact><gtr:outcomeId>rkpScXXqDHh</gtr:outcomeId><gtr:type>Membership of a guideline committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member of the International Science Advisory Council of APRI</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>D8191337-C68D-4CA0-B309-A9044F8FF50E</gtr:id><gtr:impact>The importance of this committee which I now chair is to provide scientific knowledge and expertise to the growing scientific community of the APRI</gtr:impact><gtr:outcomeId>ZWNVcPTjyBh</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member of the UK SEAC Advisory Body</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>7E0AF9AB-9643-433E-A509-81058346BAEB</gtr:id><gtr:impact>Spongiform Encephalopathy Advisory Committee advised Government on all accept of the Transmissible Spongiform Encephalopathies throughout the BSE and vCJD epidemics</gtr:impact><gtr:outcomeId>RriG7TJeFFs</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>5425C5D4-0386-4810-8374-8CFBC18E2EBC</gtr:id><gtr:title>Host PrP glycosylation: a major factor determining the outcome of prion infection.</gtr:title><gtr:parentPublicationTitle>PLoS biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0097d945b89af9e5dfa8f13841b73fd8"><gtr:id>0097d945b89af9e5dfa8f13841b73fd8</gtr:id><gtr:otherNames>Tuzi NL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1544-9173</gtr:issn><gtr:outcomeId>56c1fc78daefe4.40399075</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C9DC99AF-8D20-4826-A2F0-22714D47AC7F</gtr:id><gtr:title>Post-translational changes to PrP alter transmissible spongiform encephalopathy strain properties.</gtr:title><gtr:parentPublicationTitle>The EMBO journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/26e30d35a7c5d36181d91a4831096629"><gtr:id>26e30d35a7c5d36181d91a4831096629</gtr:id><gtr:otherNames>Cancellotti E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0261-4189</gtr:issn><gtr:outcomeId>56c1fc75734608.34337622</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1FE30A12-4E50-4520-9D3C-CD72F69E02EC</gtr:id><gtr:title>The role of host PrP in Transmissible Spongiform Encephalopathies.</gtr:title><gtr:parentPublicationTitle>Biochimica et biophysica acta</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/26e30d35a7c5d36181d91a4831096629"><gtr:id>26e30d35a7c5d36181d91a4831096629</gtr:id><gtr:otherNames>Cancellotti E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0006-3002</gtr:issn><gtr:outcomeId>56c1fc7a7d3a71.25377025</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1AC4D94D-5C38-49FD-BCC1-F57304D540C2</gtr:id><gtr:title>Evaluating the Species Barrier</gtr:title><gtr:parentPublicationTitle>Food Safety</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3aacaf55e9862f218865e4bf858df126"><gtr:id>3aacaf55e9862f218865e4bf858df126</gtr:id><gtr:otherNames>Manson J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>58bd4114bff217.68456734</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5FC18DF8-2C23-45E9-A8CB-FB6A2859EC85</gtr:id><gtr:title>Evaluating the species barriers of TSEs with transgenic mouse models</gtr:title><gtr:parentPublicationTitle>PRION</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/03592a0d82ca3a35cede52c45076cde4"><gtr:id>03592a0d82ca3a35cede52c45076cde4</gtr:id><gtr:otherNames>Manson Jean C.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1933-6896</gtr:issn><gtr:outcomeId>58bd43e3d39fc8.45673840</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6D57F96F-E135-476F-95E6-44BA0FF88B34</gtr:id><gtr:title>Glycosylation of PrPC determines timing of neuroinvasion and targeting in the brain following transmissible spongiform encephalopathy infection by a peripheral route.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/26e30d35a7c5d36181d91a4831096629"><gtr:id>26e30d35a7c5d36181d91a4831096629</gtr:id><gtr:otherNames>Cancellotti E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>56c1fc78437669.05168473</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BBS/E/A/00001655</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>